USM — United States Cellular Cashflow Statement
0.000.00%
Last trade - 00:00
- $3.05bn
- $6.00bn
- $3.91bn
- 90
- 62
- 88
- 94
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 133 | 233 | 160 | 35 | 58 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 4 | -55 | -42 | 28 | -10 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -111 | 246 | -35 | 36 | 115 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 724 | 1,237 | 802 | 832 | 866 |
Capital Expenditures | -916 | -1,160 | -2,026 | -1,187 | -738 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 52 | -3 | -10 | 8 | 17 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -864 | -1,163 | -2,036 | -1,179 | -721 |
Financing Cash Flow Items | -6 | -57 | -35 | -27 | -70 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -152 | 926 | 142 | 456 | -274 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -292 | 1,000 | -1,092 | 109 | -129 |